BACKGROUND: Healthcare cost modeling have favored early ( @entity11274 ) over interval laparoscopic cholecystectomy (ILC) for @entity14784 ( @entity14784 ). However, actual costs of treatment have never been studied. The aim of the present study was to compare actual hospital costs involved in @entity11274 and ILC in @entity1 with @entity14784 . METHODS: Retrospective study of @entity1 who underwent laparoscopic cholecystectomy for @entity14784 was conducted. Demographic, clinical, operative data and costs were extracted and analyzed. RESULTS: Between 2011 and 2013, 201 had laparoscopic surgery for @entity14784 at Tan Tock Seng Hospital, Singapore. One hundred and thirty-four (67%) @entity1 underwent @entity11274 ( <=7 days of presentation, within index admission). Median total length of stay (LOS) was 4.6 and 6.8 days for @entity11274 and ILC groups, respectively (P = 0.006). @entity1 who had @entity11274 also had significantly lesser total number of admissions (P < 0.001). The median (IQR) total inpatient costs were    4.4 * 10(3) (3.6-5.6) and    5.5 * 10(3) (4.0-7.5) for @entity11274 and ILC @entity1 , respectively (P < 0.007). Costs associated with investigations were significantly higher in the ILC group (P = 0.039), of which serological costs made most difference (P < 0.005). The ward costs were also significantly higher in the ILC group. CONCLUSION: The cost differences reflect the significantly increased total LOS, and repeat presentations associated with ILC. Therefore, @entity11274 should be the preferred management strategy for @entity14784 .

Analysis of actual healthcare costs of early versus interval cholecystectomy in XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity14784 :: ('MESH:D041881', 'Disease') :: ['acute cholecystitis', 'AC'] @entity11274 :: ('6363', 'Gene') :: ['ELC']
@entity14784 :: (MESH:D041881,Disease) :: ['acute cholecystitis']
